Warfarin dose requirement in Turkish patients: the influences of patient characteristics and polymorphisms in CYP2C9, VKORC1 and factor VII Posted on March 4, 2019July 26, 2022 by admin ORIGINAL ARTICLE Hippokratia 2014, 18(4):319-327 Yildirim E, Erol K, Birdane A Pharmacology Department, Cardiology Department Medical Faculty, Eskisehir Osmangazi University, Eskisehir, Turkey